Value stocks offer good opportunities for long-term investment in 2025, especially for investors who want stability and growth. Value stocks usually have lower ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

Franklin Resources trimmed its Pfizer stake by a smidge, selling just 25,315 shares—but when you’ve got over 16 million, ...

Learn more about whether Halozyme Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Potato producer Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to stocks offering exposure ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

At present, Healthcare’s dividend yield is 7.3% at 31 cents per share. Over a year, HR stock is up nearly 20%, effectively ...

Pfizer’s stock has underperformed lately, falling 4.6% while still doing marginally better than its peers. Analysts have made ...

Dziubinski: All right, we’ve arrived at everyone’s favorite part of the show: this week’s stock picks. Now these three stocks ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...